Related Experiment Videos

The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis

C Y Chen1, P Juo, J S Liou

  • 1Cancer Research Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA. yanyan@bu.edu

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|July 4, 2001
PubMed

Insights

Oncogenic Ras triggers apoptosis by inhibiting protein kinase C (PKC). Fas-associated death domain (FADD) and caspase-8 are crucial for this process, with c-Jun NH2-terminal kinase (JNK) acting as an upstream effector.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Signal transduction

Background:

  • Oncogenic Ras signaling is implicated in cellular apoptosis.
  • Protein Kinase C (PKC) activity inhibition is a trigger for Ras-induced apoptosis.
  • Understanding the upstream signaling pathways is critical for elucidating apoptosis execution.

Purpose of the Study:

  • To investigate the upstream elements responsible for caspase cascade activation in PKC/Ras-mediated apoptosis.
  • To determine the roles of Fas-associated death domain (FADD) and c-Jun NH2-terminal kinase (JNK) in this apoptotic pathway.

Main Methods:

  • Utilized Jurkat and Fas/FADD-defective cell lines engineered to express v-ras.
  • Assessed caspase-8 activation through FADD binding in response to Ras expression.
  • Investigated the effect of c-Jun NH2-terminal kinase (JNK) suppression using dn-JNK1 on apoptosis and FADD-caspase-8 interaction.

Main Results:

  • Caspase-8 activation, potentially via FADD, was observed in Jurkat/ras and Jurkat/Fas(m)/ras cells, but not in Jurkat/FADD(m)/ras cells.
  • JNK was activated in all ras-expressing cell lines.
  • dn-JNK1 inhibited FADD-caspase-8 interaction and partially protected cells, but did not affect apoptosis in FADD-defective cells.

Conclusions:

  • FADD/caspase-8 signaling pathway is integral to PKC/Ras-mediated apoptosis.
  • JNK activation appears to be an upstream event that facilitates caspase activation in this context.
  • These findings highlight JNK as a potential therapeutic target in Ras-driven cancers.

Related Concept Videos